Follow
Gabriela Alexe
Gabriela Alexe
Dana-Farber Cancer Institute / Harvard Medical School / Broad Institute of MIT and Harvard
Verified email at broadinstitute.org - Homepage
Title
Cited by
Cited by
Year
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1
RGW Verhaak, KA Hoadley, E Purdom, V Wang, Y Qi, MD Wilkerson, ...
Cancer cell 17 (1), 98-110, 2010
80792010
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
R McLendon, A Friedman, D Bigner, EG Van, Meir, DJ Brat, ...
Nature 455 (7216), 1061-1068, 2008
74482008
Carcinoma-associated fibroblast–like differentiation of human mesenchymal stem cells
PJ Mishra, PJ Mishra, R Humeniuk, DJ Medina, G Alexe, JP Mesirov, ...
Cancer research 68 (11), 4331-4339, 2008
10812008
Targeting MYCN in neuroblastoma by BET bromodomain inhibition
A Puissant, SM Frumm, G Alexe, CF Bassil, J Qi, YH Chanthery, ...
Cancer discovery 3 (3), 308-323, 2013
7272013
Origin and differentiation of human memory CD8 T cells after vaccination
RS Akondy, M Fitch, S Edupuganti, S Yang, HT Kissick, KW Li, ...
Nature 552 (7685), 362-367, 2017
5322017
The genomic landscape of pediatric Ewing sarcoma
BD Crompton, C Stewart, A Taylor-Weiner, G Alexe, KC Kurek, ...
Cancer discovery 4 (11), 1326-1341, 2014
5272014
MDM2 SNP309 accelerates tumor formation in a gender-specific and hormone-dependent manner
GL Bond, KM Hirshfield, T Kirchhoff, G Alexe, EE Bond, H Robins, F Bartel, ...
Cancer research 66 (10), 5104-5110, 2006
3592006
Identifying mRNA targets of microRNA dysregulated in cancer: with application to clear cell Renal Cell Carcinoma
H Liu, AR Brannon, AR Reddy, G Alexe, MW Seiler, A Arreola, JH Oza, ...
BMC systems biology 4, 1-17, 2010
3182010
Identification of a microRNA panel for clear-cell kidney cancer
D Juan, G Alexe, T Antes, H Liu, A Madabhushi, C Delisi, S Ganesan, ...
Urology 75 (4), 835-841, 2010
2732010
High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates
G Alexe, GS Dalgin, D Scanfeld, P Tamayo, JP Mesirov, C DeLisi, L Harris, ...
Cancer research 67 (22), 10669-10676, 2007
2452007
Consensus algorithms for the generation of all maximal bicliques
G Alexe, S Alexe, Y Crama, S Foldes, PL Hammer, B Simeone
Discrete Applied Mathematics 145 (1), 11-21, 2004
2302004
In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling
PG Miller, F Al-Shahrour, KA Hartwell, LP Chu, M Järĺs, RV Puram, ...
Cancer cell 24 (1), 45-58, 2013
1812013
Transforming growth factor-β signaling: emerging stem cell target in metastatic breast cancer?
AR Tan, G Alexe, M Reiss
Breast cancer research and treatment 115, 453-495, 2009
1642009
Antigen availability determines CD8+ T cell-dendritic cell interaction kinetics and memory fate decisions
SE Henrickson, M Perro, SM Loughhead, B Senman, S Stutte, M Quigley, ...
Immunity 39 (3), 496-507, 2013
1612013
Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth
TU Barbie, G Alexe, AR Aref, S Li, Z Zhu, X Zhang, Y Imamura, TC Thai, ...
The Journal of clinical investigation 124 (12), 5411-5423, 2014
1582014
Tight regulation of memory CD8+ T cells limits their effectiveness during sustained high viral load
EE West, B Youngblood, WG Tan, HT Jin, K Araki, G Alexe, BT Konieczny, ...
Immunity 35 (2), 285-298, 2011
1582011
SYK is a critical regulator of FLT3 in acute myeloid leukemia
A Puissant, N Fenouille, G Alexe, Y Pikman, CF Bassil, S Mehta, J Du, ...
Cancer cell 25 (2), 226-242, 2014
1552014
EWS/FLI confers tumor cell synthetic lethality to CDK12 inhibition in Ewing sarcoma
AB Iniguez, B Stolte, EJ Wang, AS Conway, G Alexe, NV Dharia, ...
Cancer cell 33 (2), 202-216. e6, 2018
1532018
Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation
AA Lane, B Chapuy, CY Lin, T Tivey, H Li, EC Townsend, ...
Nature genetics 46 (6), 618-623, 2014
1522014
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2
L Chen, G Alexe, NV Dharia, L Ross, AB Iniguez, AS Conway, EJ Wang, ...
The Journal of clinical investigation 128 (1), 446-462, 2018
1462018
The system can't perform the operation now. Try again later.
Articles 1–20